Search

amyloid clearance from PV interneurons in Alzheimer's disease > **Status

matched in: search_vector

amyloid precursor protein, demonstrates accelerated amyloid deposition and neuroinflammation compared

matched in: search_vector

amyloid-induced synaptic dysfunction in AD > **Status**: ✅ Validated  |  **Composite

matched in: search_vector

amyloid toxicity and trophic support. Animal models of amyloid pathology

matched in: search_vector

amyloid-β42/40 ratio, a sensitive marker of amyloid pathology

matched in: search_vector

amyloid PET. **Optimizing the Protocol** Current research focuses on: 1. **Multi

matched in: search_vector

amyloid-β oligomers triggers association with the adaptor protein DAP12

matched in: search_vector

amyloid-beta oligomers preferentially target PV interneurons through multiple mechanisms

matched in: search_vector

amyloid regeneration. Combining autophagy restoration with anti-amyloid therapy could

matched in: search_vector

amyloid-β oligomers, pro-inflammatory cytokines (TNF-α, IL-1β), and oxidative

matched in: search_vector

amyloid-β oligomers, hyperphosphorylated tau aggregates, oxidative stress, and calcium

matched in: search_vector

amyloid and other pathological substrates. Transcriptomic profiling of microglia from

matched in: search_vector

amyloid-beta oligomers, alpha-synuclein fibrils, or pathological tau conformers

matched in: search_vector

amyloid burden. This dissociation between amyloid effects (minimal) and tau effects

matched in: search_vector

amyloid burden. Critically, this strategy complements anti-amyloid agents: mice

matched in: search_vector

amyloid toxicity disrupts the normal gating of perforant path transmission

matched in: search_vector

amyloid pathology. ## Connection to Neurodegeneration The selective vulnerability of PV interneurons

matched in: search_vector

amyloid burden and microglial state in AD models (PMID: 27929004), and early

matched in: search_vector

amyloid-β or extracellular ATP, which serve as signal 2 activators

matched in: search_vector

amyloid-targeting immunotherapies, particularly regarding ARIA (amyloid-related imaging abnormalities

matched in: search_vector

amyloid-beta accumulation, and tau pathology. PV+ interneuron loss and dysfunction

matched in: search_vector

amyloid pathology and show early entorhinal cortex dysfunction, optogenetic stimulation

matched in: search_vector

amyloid plaques, with corresponding increases in IL-1β levels and pyroptotic

matched in: search_vector

amyloid pathology, treatment with the SIRT1 activator resveratrol (30 mg/kg

matched in: search_vector

amyloid and tau pathology in 5XFAD and tau P301S mice

matched in: search_vector

amyloid angiopathy (CAA)—Aβ deposits in vessel walls stiffen arteries

matched in: search_vector

amyloid clearance, enabling higher anti-amyloid dosing with improved safety

matched in: search_vector

amyloid clearance deficits through sustained IL-1β signaling. Chronic microglial

matched in: search_vector

amyloid and tau pathology in 5XFAD and tau P301S mice

matched in: search_vector

amyloid-β plaques, and reduced synaptic pruning efficiency compared to APOE3

matched in: search_vector